IWC
TLX

Integrated Wealth Concepts’s Telix Pharmaceuticals TLX Stock Holding History

Integrated Wealth Concepts’s Portfolio TLX Stock Details TLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.9M Hold
164,397
– – 0.01% 988
2026
Q1 		$1.57M Buy
+164,397
New +$1.25M 0.01% 865

Other funds holding TLX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $66.1B AUM 33.53% 1-Year Est. Return
PIC
Portland Investment Counsel Burlington, Ontario, Canada $358M AUM 26.37% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
HWAM
Hennion & Walsh Asset Management Parsippany, New Jersey $3.5B AUM 41.95% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
RBI
Raiffeisen Bank International Vienna, Austria $8.53B AUM 46.94% 1-Year Est. Return

Integrated Wealth Concepts's TLX Position: Q2 2026 in Review

Integrated Wealth Concepts held its Telix Pharmaceuticals (TLX) position steady in Q2 2026 at 164,397 shares worth $1.9M. The position accounts for 0.01% of the portfolio, ranked #988.

Integrated Wealth Concepts first reported a position in TLX in Q1 2026 and has held it in 2 quarters since. 61 funds tracked by Wall St. Rank hold TLX as of Q2 2026.

  • Integrated Wealth Concepts held 164,397 shares of Telix Pharmaceuticals worth $1.9M as of Q2 2026.
  • Integrated Wealth Concepts left its Telix Pharmaceuticals share count unchanged in Q2 2026.
  • Telix Pharmaceuticals made up 0.01% of Integrated Wealth Concepts's portfolio in Q2 2026, its #988 holding.
  • Integrated Wealth Concepts first reported a position in Telix Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 61 funds tracked by Wall St. Rank held Telix Pharmaceuticals as of Q2 2026.

Based on Integrated Wealth Concepts's 13F filing for Q2 2026, filed 12 Aug 2026.